SCHEMBL6399679

SCHEMBL6399679

Cc1ccc(N2CCC(=O)N(N)C2=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.43
DRD3 P35462 1/20 0.43
CTSG P08311 2/20 0.42
CMA1 P23946 2/20 0.42
F2 P00734 1/20 0.42
ELANE P08246 1/20 0.42
CTRC Q99895 1/20 0.42
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ALOX5 P09917 1/20 0.41
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
LMNA P02545 1/20 0.39
RAB9A P51151 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 2/20 0.38
PKM P14618 1/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6399376 0.83 DRD2 (0.43) DRD2DRD3CTSGCMA1HTT
SCHEMBL6404679 0.83 RAB9A (0.51) DRD2DRD3HTTSMN1; SMN2MAPK1
SCHEMBL6399716 0.82 MEN1 (0.59) DRD2DRD3CTSGCMA1ALOX5
SCHEMBL2710657 0.81 ALOX5 (0.48) DRD2DRD3CTSGCMA1F2
SCHEMBL6401435 0.81 L3MBTL1 (0.53) DRD2DRD3ALOX5TSHRMAPK1
SCHEMBL14337562 0.74 DRD2 (0.48) DRD2DRD3CTSGCMA1F2
SCHEMBL6400908 0.73 DDB1 (0.54) SMN1; SMN2ALOX5MEN1KMT2ADDB1
SCHEMBL6401082 0.72 DRD2 (0.47) DRD2DRD3CTSGCMA1SMN1; SMN2
SCHEMBL10973333 0.71 DDB1 (0.51) DRD2DRD3HTTSMN1; SMN2MAPK1
SCHEMBL6404669 0.71 DRD2 (0.48) DRD2DRD3ALOX5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 DRD2 1723/4885DRD3 2242/4885CTSG 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.